1. Home
  2. APAM vs HAE Comparison

APAM vs HAE Comparison

Compare APAM & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artisan Partners Asset Management Inc.

APAM

Artisan Partners Asset Management Inc.

HOLD

Current Price

$37.55

Market Cap

2.6B

Sector

Finance

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$59.45

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APAM
HAE
Founded
1994
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
APAM
HAE
Price
$37.55
$59.45
Analyst Decision
Hold
Buy
Analyst Count
5
9
Target Price
$43.00
$84.13
AVG Volume (30 Days)
719.9K
540.5K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
10.81%
N/A
EPS Growth
10.66
44.54
EPS
4.05
2.46
Revenue
$1,196,688,000.00
$910,373,000.00
Revenue This Year
$5.96
N/A
Revenue Next Year
$5.05
$5.23
P/E Ratio
$9.25
$24.42
Revenue Growth
7.63
N/A
52 Week Low
$34.99
$47.32
52 Week High
$48.46
$87.32

Technical Indicators

Market Signals
Indicator
APAM
HAE
Relative Strength Index (RSI) 50.60 49.06
Support Level $35.01 $48.47
Resistance Level $38.75 $62.78
Average True Range (ATR) 1.04 1.86
MACD 0.04 0.01
Stochastic Oscillator 58.10 31.71

Price Performance

Historical Comparison
APAM
HAE

About APAM Artisan Partners Asset Management Inc.

Artisan Partners Asset Management Inc is a investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. The company operates as one segment in the investment management business. The company generates maximum portion of its revenues from clients domiciled in countries outside the United States.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: